THEOPHYLLINE AND ANTIPYRINE DISPOSITION IN SMOKING AND NON-SMOKING EPILEPTIC SUBJECTS

被引:6
作者
ACHESON, DWK
UDEN, S
BRAGANZA, JM
BROWN, SW
HOUSTON, JB
机构
[1] UNIV MANCHESTER,DEPT PHARM,MANCHESTER M13 9PL,LANCS,ENGLAND
[2] UNIV MANCHESTER,MANCHESTER ROYAL INFIRM,DEPT GASTROENTEROL,MANCHESTER M13 9WL,LANCS,ENGLAND
[3] DAVID LEWIS CTR EPILEPSY,WARFORD,CHESHIRE,ENGLAND
关键词
D O I
10.1111/j.1365-2125.1987.tb03250.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:812 / 815
页数:4
相关论文
共 16 条
[1]   INDUCTION OF CYTOCHROMES-P-450 IN PANCREATIC DISEASE - CONSEQUENCE, COINCIDENCE OR CAUSE [J].
ACHESON, DWK ;
ROSE, P ;
HOUSTON, JB ;
BRAGANZA, JM .
CLINICA CHIMICA ACTA, 1985, 153 (02) :73-84
[2]   EFFECTS OF TOBACCO SMOKING AND ORAL-CONTRACEPTIVE USE ON THEOPHYLLINE DISPOSITION [J].
GARDNER, MJ ;
TORNATORE, KM ;
JUSKO, WJ ;
KANARKOWSKI, R .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 16 (03) :271-280
[3]   DIFFERENTIAL-EFFECTS OF CIMETIDINE ON THEOPHYLLINE METABOLIC PATHWAYS [J].
GRYGIEL, JJ ;
MINERS, JO ;
DREW, R ;
BIRKETT, DJ .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 26 (03) :335-340
[4]   CIGARETTE-SMOKING AND THEOPHYLLINE CLEARANCE AND METABOLISM [J].
GRYGIEL, JJ ;
BIRKETT, DJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (04) :491-496
[5]  
HUNT SN, 1976, CLIN PHARMACOL THER, V19, P546
[6]   PHARMACOKINETIC DRUG-INTERACTIONS WITH THEOPHYLLINE [J].
JONKMAN, JHG ;
UPTON, RA .
CLINICAL PHARMACOKINETICS, 1984, 9 (04) :309-334
[7]  
LU AYH, 1980, PHARMACOL REV, V31, P277
[8]   PHENYTOIN THEOPHYLLINE INTERACTION [J].
MARQUIS, JF ;
CARRUTHERS, SG ;
SPENCE, JD ;
BROWNSTONE, YS ;
TOOGOOD, JH .
NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (19) :1189-1190
[9]  
MINERS JO, 1985, DRUG METAB DISPOS, V13, P598
[10]   THE P450 GENE SUPERFAMILY - RECOMMENDED NOMENCLATURE [J].
NEBERT, DW ;
ADESNIK, M ;
COON, MJ ;
ESTABROOK, RW ;
GONZALEZ, FJ ;
GUENGERICH, FP ;
GUNSALUS, IC ;
JOHNSON, EF ;
KEMPER, B ;
LEVIN, W ;
PHILLIPS, IR ;
SATO, R ;
WATERMAN, MR .
DNA-A JOURNAL OF MOLECULAR & CELLULAR BIOLOGY, 1987, 6 (01) :1-11